1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SAGE THERAPEUTICS INC
Sage Therapeutics Inc XNAS: SAGE

Sage Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Momentum Trap
about

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting ...

Read More
9.17 0.02 (0.22%)
31.92% Fall from 52W High
1.1M
XNAS Volume

XNAS 15 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
5.6 / 100
Valuation Score
Expensive Valuation
16.2 / 100
Momentum Score
Technically Moderately Bullish
63.4 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
9
1Yr Price target downside is -5%
15 analysts

19

S

7

W

1

O

2

T

SWOT Analysis

Sage Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..